During the past decade, University Hospitals Sussex NHS Foundation Trust conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "University Hospitals Sussex NHS Foundation Trust" are "Amyotrophic Lateral Sclerosis" (1 trials), "Antibiotic Duration" (1 trials), "Cellulitis" (1 trials), "Cellulitis of Leg" (1 trials) and "Motor Neuron Disease" (1 trials). Many other conditions were trialed in "University Hospitals Sussex NHS Foundation Trust" in a lesser frequency.

Most popular intervention types in "University Hospitals Sussex NHS Foundation Trust" are "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Pegcetacoplan (APL-2)" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "University Hospitals Sussex NHS Foundation Trust" are 2 trials for "All" genders.

Currently, there are NaN active trials in "University Hospitals Sussex NHS Foundation Trust". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in University Hospitals Sussex NHS Foundation Trust, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in University Hospitals Sussex NHS Foundation Trust, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".